| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 57,224 | 66,560 | 65,394 | | Cost of Revenue | 32,470 | 33,811 | 37,547 | | | Gross Profit | 24,754 | 32,749 | 27,847 | | | Operating Expenses | | Research Development | 13,099 | 13,572 | 13,276 | | Selling General and Administrative | 18,092 | 20,081 | 18,533 | | Non Recurring | 884 | 26,796 | 1,840 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,321) | (27,700) | (5,802) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,343 | 2,767 | 2,755 | | Earnings Before Interest And Taxes | (5,978) | (24,933) | (3,047) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (5,978) | (24,933) | (3,047) | | Income Tax Expense | 1,137 | 1,220 | (1,213) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,115) | (26,153) | (1,834) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,115) | (26,153) | (1,834) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,115) | ($26,153) | ($1,834) |
|
0.13% Nasdaq 
Income Statement
